XSpray Pharma AB (publ)
F:6XP
XSpray Pharma AB (publ)
F:6XP
Price:
1.366
EUR
0.89%
Market Cap:
€39.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
|
I
|
ImmunoGen Inc
XMUN:IMU
|
US |
|
J
|
Juventus FC SpA
XMUN:JUVE
|
IT |
|
M
|
Manulife Financial Corp
F:MLU
|
CA |
|
E
|
eBay Inc
DUS:EBA
|
US |
|
E
|
EnBW Energie Baden Wuerttemberg AG
DUS:EBK
|
DE |
|
C
|
Companhia Energetica de Minas Gerais CEMIG
NYSE:CIG
|
BR |
|
Health and Happiness (H&H) International Holdings Ltd
F:8BI
|
HK |
|
Sona BLW Precision Forgings Ltd
BSE:543300
|
IN |
|
P
|
Poly Medicure Ltd
BSE:531768
|
IN |
|
F
|
First American Financial Corp
F:Y1F
|
US |
|
K
|
Kingsgate Consolidated Ltd
F:KCN
|
AU |
|
First American Financial Corp
NYSE:FAF
|
US |
Wall St Price Targets
6XP Price Targets Summary
XSpray Pharma AB (publ)
XSpray Pharma AB (publ)
Wall Street analysts forecast 6XP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 6XP is 7.473 EUR with a low forecast of 7.399 EUR and a high forecast of 7.692 EUR.
Lowest Forecast
Price Target
7.399
EUR
442% Upside
Average Forecast
Price Target
7.473
EUR
447% Upside
Highest Forecast
Price Target
7.692
EUR
463% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6XP's stock price target?
Price Target
7.473
EUR
7.473
EUR
According to Wall Street analysts, the average 1-year price target for 6XP is 7.473 EUR with a low forecast of 7.399 EUR and a high forecast of 7.692 EUR.
